The regulation of epidermal melanogenesis via cAMP and/or PKC signaling pathways: insights for the development of hypopigmenting agents

[1]  Ji-Young Kim,et al.  Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma. , 2013, The Journal of investigative dermatology.

[2]  Ai-Young Lee,et al.  Histamine receptor 2-mediated growth-differentiation factor-15 expression is involved in histamine-induced melanogenesis. , 2012, The international journal of biochemistry & cell biology.

[3]  Nan-Hyung Kim,et al.  PDZK1 upregulation in estrogen-related hyperpigmentation in melasma. , 2012, The Journal of investigative dermatology.

[4]  Jian-Zhong Zhang,et al.  Effect of kappa elastin on melanogenesis in A375 human melanoma cells and its related mechanism. , 2012, Chinese Medical Journal.

[5]  J. Wikberg,et al.  Dermal Melanocortin Receptor Rebound in Diffuse Systemic Sclerosis after Anti‐TGFβ1 Antibody Therapy , 2012, Scandinavian journal of immunology.

[6]  H. Shimoda,et al.  β‐Cryptoxanthin suppresses UVB‐induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte‐stimulating hormone pathways , 2012, The Journal of pharmacy and pharmacology.

[7]  H. Isoda,et al.  Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray. , 2012, Journal of dermatological science.

[8]  K. Wakamatsu,et al.  Abrogating effect of a xanthophyll carotenoid astaxanthin on the stem cell factor-induced stimulation of human epidermal pigmentation , 2012, Archives of Dermatological Research.

[9]  K. Wakamatsu,et al.  Withania somnifera extract attenuates stem cell factor-stimulated pigmentation in human epidermal equivalents through interruption of ERK phosphorylation within melanocytes , 2012, Journal of Natural Medicines.

[10]  Wei Chen,et al.  Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells , 2011, Steroids.

[11]  C. Liang.  Ov‐16 [4‐(3,4‐dihydroxybenzoyloxymethyl)phenyl‐O‐β‐D‐glucopyranoside] inhibits melanin synthesis by regulating expressions of melanogenesis‐regulated gene and protein , 2011, Experimental dermatology.

[12]  Tzung-Han Chou,et al.  Antioxidant and Antimelanogenic Behaviors of Paeonia suffruticosa , 2011, Plant foods for human nutrition.

[13]  K. Wakamatsu,et al.  An Extract of Withania somnifera Attenuates Endothelin‐1‐stimulated Pigmentation in Human Epidermal Equivalents through the Interruption of PKC Activity Within Melanocytes , 2011, Phytotherapy research : PTR.

[14]  Z. Abdel‐Malek,et al.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.

[15]  K. Wakamatsu,et al.  An extract of Melia toosendan attenuates endothelin-1-stimulated pigmentation in human epidermal equivalents through the interruption of PKC activity within melanocytes , 2011, Archives of Dermatological Research.

[16]  Nan-Hyung Kim,et al.  Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival , 2010, Experimental dermatology.

[17]  Kenichi Umishio,et al.  Inhibitory Effect of Elephantopus mollis H.B. and K. Extract on Melanogenesis in B16 Murine Melanoma Cells by Downregulating Microphthalmia-Associated Transcription Factor Expression , 2010, Bioscience, biotechnology and biochemistry.

[18]  H. Shimoda,et al.  Anti‐pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules , 2010, The Journal of pharmacy and pharmacology.

[19]  G. Bepler,et al.  Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer. , 2010, Clinical lung cancer.

[20]  J. Wood,et al.  Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells , 2009, Experimental dermatology.

[21]  K. Wakamatsu,et al.  Prolonged treatment of fair‐skinned mice with topical forskolin causes persistent tanning and UV protection , 2009, Pigment cell & melanoma research.

[22]  Ji-Young Kim,et al.  Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration , 2009, Pigment cell & melanoma research.

[23]  T. Saida,et al.  Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin , 2008, Pigment cell & melanoma research.

[24]  Yinshi Guo,et al.  Inhibition of PAX3 by TGF-beta modulates melanocyte viability. , 2008, Molecular cell.

[25]  L. Denner,et al.  Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells , 2008, Molecular and Cellular Endocrinology.

[26]  G. Costin,et al.  Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. , 2008, Current drug targets.

[27]  Yin-kun Liu,et al.  Involvement of protein kinase C β–extracellular signal‐regulating kinase1/2/p38 mitogen‐activated protein kinase–heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion , 2008, Cancer science.

[28]  T. Dadd,et al.  SLC24A5 Encodes a trans-Golgi Network Protein with Potassium-dependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal Melanogenesis* , 2008, Journal of Biological Chemistry.

[29]  Songhee Jeon,et al.  Bee venom stimulates human melanocyte proliferation, melanogenesis, dendricity and migration , 2007, Experimental & Molecular Medicine.

[30]  J. Lytton.  Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. , 2007, The Biochemical journal.

[31]  J. Hwang,et al.  [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs. , 2007, Biochemical pharmacology.

[32]  M. Eller,et al.  Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin‐1 receptor expression in the hair follicle , 2007, Experimental dermatology.

[33]  J. Lytton.  REVIEW ARTICLE Na + /Ca 2+ exchangers: three mammalian gene families control Ca 2+ transport , 2007 .

[34]  C. Lynde,et al.  Topical treatments for melasma and postinflammatory hyperpigmentation. , 2006, Skin therapy letter.

[35]  E. Steingrímsson,et al.  The Microphthalmia-Associated Transcription Factor Mitf Interacts with β-Catenin To Determine Target Gene Expression , 2006, Molecular and Cellular Biology.

[36]  Sun-Hee Kim,et al.  Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling , 2006, Molecular Pharmacology.

[37]  A. Rademaker,et al.  The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. , 2006, The Journal of investigative dermatology.

[38]  J. Blenis,et al.  MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.

[39]  B. Gilchrest,et al.  MITF mediates cAMP-induced protein kinase C-β expression in human melanocytes , 2006 .

[40]  L. FitzGerald,et al.  Effect of MELANOTAN®, [Nle4, D-Phe7]-α-MSH, on melanin synthesis in humans with MC1R variant alleles , 2006, Peptides.

[41]  B. Gilchrest,et al.  MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. , 2006, The Biochemical journal.

[42]  L. FitzGerald,et al.  Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. , 2006, Peptides.

[43]  Keith C. Cheng,et al.  SLC24A5, a Putative Cation Exchanger, Affects Pigmentation in Zebrafish and Humans , 2005, Science.

[44]  E. Abraham,et al.  Involvement of PKCα/β in TLR4 and TLR2 dependent activation of NF-κB , 2005 .

[45]  T. Hirobe.  Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. , 2005, Pigment cell research.

[46]  E. Abraham,et al.  Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB. , 2005, Cellular signalling.

[47]  A. Goh,et al.  Imatinib mesylate causes hypopigmentation in the skin , 2004, Cancer.

[48]  Satoshi Itami,et al.  Mesenchymal–epithelial interactions in the skin , 2004, The Journal of cell biology.

[49]  B. Gilchrest,et al.  Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. , 2004, The Journal of investigative dermatology.

[50]  G. Imokawa,et al.  Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes. , 2003, Pigment cell research.

[51]  E. Price,et al.  A Tissue-restricted cAMP Transcriptional Response , 2003, Journal of Biological Chemistry.

[52]  Kazuhiro Takahashi,et al.  Microphthalmia-associated transcription factor in the Wnt signaling pathway. , 2003, Pigment cell research.

[53]  David E Fisher,et al.  Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival , 2003, Oncogene.

[54]  A. Messenger,et al.  Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin , 2003, Experimental dermatology.

[55]  A. Tarakhovsky,et al.  Protein Kinase C (cid:2) Controls Nuclear Factor (cid:3) B Activation in B Cells Through Selective Regulation of the I (cid:3) B Kinase (cid:4) , 2002 .

[56]  Kazuhiro Takahashi,et al.  Microphthalmia‐associated transcription factor interacts with LEF‐1, a mediator of Wnt signaling , 2002, The EMBO journal.

[57]  A. Hachiya,et al.  Biochemical Characterization of Endothelin-converting Enzyme-1α in Cultured Skin-derived Cells and Its Postulated Role in the Stimulation of Melanogenesis in Human Epidermis* , 2002, The Journal of Biological Chemistry.

[58]  S. MacNeil,et al.  Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. , 2002, Pigment cell research.

[59]  M. Brilliant.  The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. , 2001, Pigment cell research.

[60]  W. Cao,et al.  Group I secreted PLA2 in the maintenance of human lower esophageal sphincter tone. , 2000, Gastroenterology.

[61]  F. Camacho,et al.  Management of Facial Hyperpigmentation , 2000, American journal of clinical dermatology.

[62]  R. Paus,et al.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.

[63]  R. Buscà,et al.  Cyclic AMP a key messenger in the regulation of skin pigmentation. , 2000, Pigment cell research.

[64]  S. Inoue,et al.  Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. , 2000, The Journal of investigative dermatology.

[65]  E. Price,et al.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. , 2000, Genes & development.

[66]  T. Hunter,et al.  Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility , 2000, Nature Genetics.

[67]  B. Gilchrest,et al.  Signaling pathways mediating melanogenesis. , 1999, Cellular and molecular biology.

[68]  F. Solano,et al.  Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. , 1999, Cellular and molecular biology.

[69]  B. Molinari,et al.  Changes in H2 receptor expression and coupling during Ca2+-induced differentiation in mouse epidermal keratinocytes , 1999, Inflammation Research.

[70]  Inoue,et al.  Modulation of melanocyte‐stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin‐1α, interleukin‐1β, endothelin‐1 and tumour necrosis factor‐α , 1998 .

[71]  M. B. Davis,et al.  Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[72]  A. Brunet,et al.  Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation* , 1998, The Journal of Biological Chemistry.

[73]  Giovanni Romeo,et al.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease , 1998, Nature Genetics.

[74]  G. Barsh,et al.  Modulation of murine melanocyte function in vitro by agouti signal protein , 1997, The EMBO journal.

[75]  Y. Ao,et al.  Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. , 1996, Experimental Cell Research.

[76]  M. Eller,et al.  Mechanisms of Ultraviolet Light‐Induced Pigmentation , 1996, Photochemistry and photobiology.

[77]  D. I. Våge,et al.  The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.

[78]  G. Imokawa,et al.  Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. , 1995, The Journal of investigative dermatology.

[79]  J. Ohanian,et al.  Ultraviolet radiation stimulates a biphasic pattern of 1,2-diacylglycerol formation in cultured human melanocytes and keratinocytes by activation of phospholipases C and D. , 1995, The Biochemical journal.

[80]  R. Leurs,et al.  Molecular pharmacological aspects of histamine receptors. , 1995, Pharmacology & therapeutics.

[81]  B. Gilchrest,et al.  The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. , 1993, The Journal of biological chemistry.

[82]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.

[83]  C. Baldwin,et al.  Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). , 1993, American journal of human genetics.

[84]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[85]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[86]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  L. Tartaglia,et al.  The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[88]  S. Orlow,et al.  Interactions between ultraviolet light and interleukin-1 on MSH binding in both mouse melanoma and human squamous carcinoma cells. , 1991, Biochemical and biophysical research communications.

[89]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[90]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[91]  B. Gilchrest,et al.  Human melanogenesis is stimulated by diacylglycerol. , 1989, The Journal of investigative dermatology.

[92]  J. Pawelek,et al.  UVB-induced melanogenesis may be mediated through the MSH-receptor system. , 1989, The Journal of investigative dermatology.

[93]  H. Tagami,et al.  Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn. , 1989, Dermatologica.

[94]  D. Sibley,et al.  Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation , 1987, Nature.

[95]  B. Fuller,et al.  Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. , 1987, The Journal of biological chemistry.